Clin2
NCT07357597Possibly a fitRecruiting

Preventing mouth sores during breast or lung cancer treatment

Stomatitis

Treatments studied

Part of Mouth & dental clinical trials.

This trial tests whether a steroid mouthwash can prevent mouth sores caused by the drug Datopotamab Deruxtecan (Dato-DXd). It is for people with certain types of advanced breast cancer or lung cancer who are about to start Dato-DXd for the first time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have advanced breast cancer (HR+/HER2- or triple-negative) or advanced lung cancer with an EGFR mutation
  • You have not yet received any dose of Dato-DXd
  • You are willing to use a steroid mouthwash every time you get the drug
  • You are 18 or older and able to care for yourself (ECOG 0 or 1)
  • You do not have active mouth sores or infections in your mouth
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07543978Not yet recruiting· Phase 3
Traditional Chinese Medicine to Prevent Mouth Sores from Head/Neck Cancer Radiation

This study tests whether traditional Chinese medicine can help prevent painful mouth sores that often develop during radiation therapy for head and neck cancers. If it works, it could reduce pain and improve quality of life during treatment.

NCT07291037Recruiting· Phase 3
Study of datopotamab deruxtecan vs docetaxel for advanced lung cancer

This trial tests a new drug, datopotamab deruxtecan, against a standard chemotherapy (docetaxel) for people with advanced non-squamous lung cancer that has gotten worse after previous treatment. It is for those who do not have certain genetic changes (like EGFR, ALK, or ROS1) and whose tumors have a protein called TROP2.

Chandler, Arizona
NCT06974604Recruiting· Phase 2
Mouthwash to prevent mouth sores from Datopotamab deruxtecan

This trial tests if a dexamethasone mouthwash can prevent painful mouth sores (stomatitis) caused by the cancer drug Datopotamab deruxtecan (Dato-DXd). It's for people with certain types of advanced lung or breast cancer who have already tried other treatments.

Providence, Rhode Island
NCT07287826Recruiting· Phase 4
Steroid mouthwash to prevent mouth sores during chemo

This trial tests if using a steroid mouthwash can prevent painful mouth sores caused by certain chemotherapy drugs. It aims to help patients who are starting or already receiving chemotherapy known to cause mouth sores.

Baton Rouge, Louisiana
NCT06934733Not yet recruiting
Testing if ice therapy prevents mouth sores from breast cancer treatment

This trial tests whether sucking on ice (oral cryotherapy) during a specific type of chemo called TROP2-ADC can prevent or reduce painful mouth sores in people with advanced breast cancer. If you're starting this treatment for the first time, you may be able to join.

Zhengzhou, Henan
NCT07327216Recruiting· Phase 3
Comparing two inhalations for mouth sores from cancer treatment

This trial tests if an inhaled medication called Sapylin can prevent or reduce severe mouth sores caused by chemoradiation, compared to a standard steroid inhalation. It is for people with advanced nasopharyngeal cancer who have not yet started treatment.

Zhanjiang, Guangdong

Hear when a new Stomatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.